Quebec SEAO #INSPQ-10830

INSPQ intends to acquire 100 NxTAG respiratory pathogen panel kits

The Institut national de santé publique du Québec is seeking respiratory pathogen testing kits for public health surveillance. - Government buyer: Institut national de santé publique du Québec (INSPQ), through the Laboratoire de santé publique du Québec (LSPQ). - OEM/vendor: DiaSorin (Luminex) is identified as the supplier of the requested kits. - Product and quantity: 100 NxTAG Respiratory Pathogen Panel v2 (IVD-CA) kits; no part number is provided. - Purpose and capability: Each panel is intended to detect 21 respiratory pathogens and support influenza vaccine-effectiveness, mortality, and morbidity surveillance. - Notable considerations: INSPQ cites the laboratory work required to validate and implement an alternative, as well as potential compatibility issues, delays, service interruptions, and effects on surveillance data and operating costs. - Procurement context: The notice describes an intended direct purchase; other suppliers may demonstrate that they can meet the requirements.

Description

The Institut national de santé publique du Québec (INSPQ), through the Laboratoire de santé publique du Québec (LSPQ), intends to purchase 100 NxTAG Respiratory Pathogen Panel v2 (IVD-CA) kits from Diasorin (Luminex). The kits detect 21 respiratory pathogens and are used in influenza vaccine-effectiveness and influenza-related mortality and morbidity surveillance. This is a notice of intent to award a supply contract by mutual agreement, not a competitive call for tenders; interested suppliers may respond by demonstrating that they can meet the requirements. Responses will help determine whether a public call for tenders is appropriate.

View original listing